A decade-long Swedish study reveals that aspiration pneumonia is the leading cause of death in late-stage Parkinson's disease, accounting for 1 in 3 deaths. Survival rates drop sharply — only 15% of patients were alive at 7 years. Worse motor function, depression, and cognitive decline were each independently linked to higher mortality risk.
A prospective Swedish study tracking 107 late-stage Parkinson's disease (PD) patients for up to a decade has shed new light on what's actually killing this population — and the answer is largely aspiration pneumonia. The condition, driven by swallowing difficulties common in advanced PD, accounted for 34% of all deaths. Other causes included sepsis (16%), unspecified pneumonia (13%), ileus (5%), and COVID-19 (5%).
Survival in this group declined steeply over time, with only 31% of patients alive at 5 years and a mere 8% surviving to the final follow-up. Beyond the primary cause of death, researchers found that worse motor function, depressive symptoms, and cognitive decline each independently predicted a higher risk of mortality — even after adjusting for other factors.
By the Numbers:
Why it matters: These real-world findings give clinicians a clearer picture of end-of-life trajectories in late-stage PD. Recognizing aspiration risk and monitoring motor, cognitive, and mood symptoms could help optimize care and improve quality of life for patients and families navigating this difficult stage.
